Results 291 to 300 of about 92,559 (349)
Advanced Healthcare Materials, EarlyView.Few‐layered three dimansional conductive graphene foams are promising cytocompatible platforms to transdifferentiate mesenchymal stem cells into Schwann cell‐like phenotypes using electrical and microstructural cues. Applied electrical stimulation conditions resulted in activation of MAPK, neurotrphin and RAS signaling pathways that led to upregulation
Ekin G. Simsar +9 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Cleft Palate Craniofacial Journal, 2000
The search for the ideal bone substitute began hundreds of years ago, and continues today. While numerous choices have been proposed and tested, with varying degrees of success, there remain many challenges related to the use of bone substitutes in craniofacial reconstruction.
H F, Sailer, F E, Weber
openaire +4 more sources
The search for the ideal bone substitute began hundreds of years ago, and continues today. While numerous choices have been proposed and tested, with varying degrees of success, there remain many challenges related to the use of bone substitutes in craniofacial reconstruction.
H F, Sailer, F E, Weber
openaire +4 more sources
Der Orthopade, 2003
A large variety of different bone substitutes are available for the treatment of congenital or acquired bone defects as an alternative to bone transplantation. Complications associated with graft harvesting, limited donor resources, and the potential risk of transmission of infectious diseases have led to the development of multiple concepts of new ...
K.R. Swartz, G.R. Trost
+5 more sources
A large variety of different bone substitutes are available for the treatment of congenital or acquired bone defects as an alternative to bone transplantation. Complications associated with graft harvesting, limited donor resources, and the potential risk of transmission of infectious diseases have led to the development of multiple concepts of new ...
K.R. Swartz, G.R. Trost
+5 more sources
Periodontology 2000, 1999
Bone replacement grafts will play a continuing role in periodontal and other regenerative therapy. Several choices are available to the clinician including autogenous, allogeneic, xenogeneic and a variety of alloplastic materials. Except for fresh autogenous bone, bone replacement graft(s) do not provide the cellular elements necessary for osteogenesis
H F, Nasr +2 more
openaire +2 more sources
Bone replacement grafts will play a continuing role in periodontal and other regenerative therapy. Several choices are available to the clinician including autogenous, allogeneic, xenogeneic and a variety of alloplastic materials. Except for fresh autogenous bone, bone replacement graft(s) do not provide the cellular elements necessary for osteogenesis
H F, Nasr +2 more
openaire +2 more sources
The Lancet, 1999
Bone is the most commonly transplanted tissue except for blood. An autogenous bone graft was first used successfully in 1875 when Nussbaum harvested the ulna for bone to correct a skeletal defect? Today, in the U S A alone, autogenous bone grafting is done in about 200 000 surgical cases annually.
A, Van Heest, M, Swiontkowski
openaire +2 more sources
Bone is the most commonly transplanted tissue except for blood. An autogenous bone graft was first used successfully in 1875 when Nussbaum harvested the ulna for bone to correct a skeletal defect? Today, in the U S A alone, autogenous bone grafting is done in about 200 000 surgical cases annually.
A, Van Heest, M, Swiontkowski
openaire +2 more sources
Expert Review of Medical Devices, 2006
The current gold standard of bone grafts is the autograft since it possesses all the characteristics necessary for new bone growth, namely osteoconductivity, osteogenicity and osteoinductivity. However, the autograft has its limitations, including donor-site morbidity and supply limitations, hindering this as an option for bone repair.
Cato, Laurencin +2 more
openaire +2 more sources
The current gold standard of bone grafts is the autograft since it possesses all the characteristics necessary for new bone growth, namely osteoconductivity, osteogenicity and osteoinductivity. However, the autograft has its limitations, including donor-site morbidity and supply limitations, hindering this as an option for bone repair.
Cato, Laurencin +2 more
openaire +2 more sources
Hand Clinics, 2012
Replacement of missing bone stock is a reconstructive challenge to upper extremity surgeons and decision-making with regards to available choices remains difficult. Preference is often given to autograft in the form of cancellous, cortical, or corticocancellous grafts from donor sites.
Reena A, Bhatt, Tamara D, Rozental
openaire +2 more sources
Replacement of missing bone stock is a reconstructive challenge to upper extremity surgeons and decision-making with regards to available choices remains difficult. Preference is often given to autograft in the form of cancellous, cortical, or corticocancellous grafts from donor sites.
Reena A, Bhatt, Tamara D, Rozental
openaire +2 more sources
Bone Healing and Bone Substitutes
Facial Plastic Surgery, 2002With the advent of new biomaterials and surgical techniques, the reconstructive surgeon has a wider range of treatment modalities for the rehabilitation and reconstruction of craniofacial skeletal deformities than ever before. These innovative substances act as true bone graft substitutes, thereby allowing the surgeon to avoid the use of autogenous ...
Peter D, Costantino +3 more
openaire +2 more sources
European Journal of Orthopaedic Surgery & Traumatology, 1999
Biocompatible calcium phosphate ceramics has been used for several years in orthopeadic surgery. We have been using two new synthetic biphasic calcium phosphate ceramics (BCP) since September 1996 for bone defect filling in any orthopaedic or trauma operation where autograft use was not possible or even wanted.
C. Schwartz +3 more
openaire +1 more source
Biocompatible calcium phosphate ceramics has been used for several years in orthopeadic surgery. We have been using two new synthetic biphasic calcium phosphate ceramics (BCP) since September 1996 for bone defect filling in any orthopaedic or trauma operation where autograft use was not possible or even wanted.
C. Schwartz +3 more
openaire +1 more source